| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.37▲ | 0.37▲ | 0.37▲ | 0.40▼ | 0.45▼ |
| MA10 | 0.37▲ | 0.38▼ | 0.39▼ | 0.42▼ | 0.50▼ |
| MA20 | 0.39▼ | 0.40▼ | 0.41▼ | 0.44▼ | 0.57▼ |
| MA50 | 0.42▼ | 0.42▼ | 0.43▼ | 0.50▼ | 0.64▼ |
| MA100 | 0.43▼ | 0.46▼ | 0.49▼ | 0.58▼ | 2.05▼ |
| MA200 | 0.49▼ | 0.54▼ | 0.58▼ | 0.69▼ | 34.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.003▼ | -0.004▼ | -0.003▼ | -0.003▼ |
| RSI | 40.481▼ | 35.667▼ | 32.436▼ | 33.984▼ | 34.808▼ |
| STOCH | 15.247▼ | 5.521▼ | 4.286▼ | 31.082 | 17.066▼ |
| WILL %R | -61.945 | -75.741▼ | -75.741▼ | -66.434 | -85.000▼ |
| CCI | -18.994 | -49.898 | -77.795 | -200.881▼ | -139.801▼ |
|
Thursday, September 24, 2020 10:34 AM
The FDA has signed off on an investigator sponsored Phase 1 trial for Advaxis' (NASDAQ:ADXS) ADXS-504, off-the-shelf neoantigen ADXS-HOT program candidate for prostate cancer.The company plans to ...
|
|
Thursday, September 24, 2020 05:16 AM
Strategic transition to Investigator sponsored IND from previously announced Advaxis sponsored INDInitiation of investigator sponsored Phase 1 ...
|
|
Saturday, September 05, 2020 07:55 AM
04, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/20 | 0.352 | 0.399 | 0.34 | 0.388 | 2,605,200 |
| 24/09/20 | 0.479 | 0.483 | 0.355 | 0.367 | 9,705,200 |
| 23/09/20 | 0.421 | 0.425 | 0.382 | 0.385 | 1,115,600 |
| 22/09/20 | 0.42 | 0.428 | 0.413 | 0.424 | 709,500 |
| 21/09/20 | 0.44 | 0.44 | 0.4022 | 0.4161 | 710,962 |
| 18/09/20 | 0.431 | 0.449 | 0.43 | 0.445 | 425,300 |
| 17/09/20 | 0.45 | 0.45 | 0.421 | 0.434 | 785,000 |
| 16/09/20 | 0.447 | 0.455 | 0.44 | 0.442 | 431,100 |
| 15/09/20 | 0.457 | 0.457 | 0.437 | 0.44 | 688,500 |
| 14/09/20 | 0.44 | 0.45 | 0.435 | 0.445 | 317,000 |
|
|
||||
|
|
||||
|
|